Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
Clinical trial NCT06336330 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06336330
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-25
- Primary completion
- 2026-12-31
- Enrollment
- 831
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.